Related Experiment Video
Updated: Feb 4, 2026

Robotic-assisted Left Pneumonectomy For Vanishing Lung Syndrome
Published on: January 23, 2026
Diuretics in the Management of Cardiorenal Syndrome
Chandrika Chitturi1, James E Novak1
1Henry Ford Hospital, Detroit, MI.
Insights
Cardiovascular disease impacts heart and kidney function. This review explores cardiorenal syndrome, loop diuretics, and evidence-based strategies for managing heart failure congestion.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Cardiovascular disease is a leading global cause of death.
- Heart and kidney dysfunction are interdependent, with over 60% of heart failure patients developing chronic kidney disease.
- Volume overload and congestion are key indicators of heart failure, linked to poor prognosis.
Purpose of the Study:
- To review the pathophysiology of cardiorenal syndrome.
- To discuss the pharmacology of loop diuretics.
- To examine mechanisms of diuretic resistance and evidence-based treatment paradigms for heart failure.
Main Methods:
- Literature review of cardiorenal syndrome.
- Analysis of loop diuretic pharmacology.
- Synthesis of evidence regarding diuretic resistance and treatment.
Main Results:
- Diuretics are crucial for managing heart failure congestion but treatment is often empirical.
- Understanding cardiorenal syndrome pathophysiology is essential for effective management.
- Evidence-based guidelines for diuretic use in heart failure are lacking.
Conclusions:
- Effective management of cardiorenal syndrome requires a comprehensive understanding of the interplay between heart and kidney.
- Further research is needed to develop evidence-based diuretic treatment strategies for heart failure.
- Optimizing diuretic therapy can improve outcomes for patients with cardiorenal syndrome.
Abstract:
The leading cause of death worldwide is cardiovascular disease. The heart and the kidneys are functionally interdependent, such that dysfunction in one organ may cause dysfunction in the other. By one estimate, more than 60% of patients with congestive heart failure develop chronic kidney disease. Volume overload and congestion are hallmarks of heart failure, and these findings are associated with severe symptoms and poor outcomes. Given the importance of congestion, diuretics remain a cornerstone of heart failure management. However, diuretic treatment remains largely empirical, with little evidence currently available to guide decisions. In this review, we discuss the pathophysiology of cardiorenal syndrome, the pharmacology of loop diuretics, mechanisms of diuretic resistance, and evidence-based treatment paradigms.
Related Concept Videos
Acute Coronary Syndrome V: Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Nephrotic Syndrome III : Nursing Management
Irritable Bowel Syndrome III: Medical and Nursing Management
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics

